Overview
Background
Dr Melanie Robitaille is a Senior Post-Doctoral Researcher working with the Calcium Signalling in Therapeutics Team (CaSTT) in the School of Pharmacy. This team specializes in the development and application of novel methodologies and cellular assays in drug discovery, including the use of genetically encoded indicator for high-content imaging in live cells.
Her interests are to elucidate how calcium signals are remodelled in disease states, to identify calcium transporters as new therapeutic targets and to develop molecular and cellular screening tools to be used in drug development programs. She has an established profile in cellular and molecular biology, with high expertise in plasmid cloning, lentiviral transduction and the use of CRISPR/Cas9 to modulate gene expression.
Availability
- Dr Melanie Robitaille is:
- Not available for supervision
Fields of research
Qualifications
- Doctor of Philosophy, Université de Montréal
Works
Search Professor Melanie Robitaille’s works on UQ eSpace
2006
Journal Article
Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking
Dupre, Denis J., Robitaille, Melanie, Ethier, Nathalie, Villeneuve, Louis R., Mamarbachi, Aida M. and Hebert, Terence E. (2006). Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. Journal of Biological Chemistry, 281 (45), 34561-34573. doi: 10.1074/jbc.M605012200
2006
Journal Article
Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells
Rebois, R. Victor, Robitaille, Melanie, Gales, Celine, Dupre, Denis J., Baragli, Alessandra, Trieu, Phan, Ethier, Nathalie, Bouvier, Michel and Hebert, Terence E. (2006). Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells. Journal of Cell Science, 119 (13), 2807-2818. doi: 10.1242/jcs.03021
Supervision
Availability
- Dr Melanie Robitaille is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
The intersection between calcium signaling pathways and coronavirus infection
Principal Advisor
Other advisors: Professor Gregory Monteith, Dr Larisa Labzin
-
Master Philosophy
Characterisation of novel Dynorphin analogues targeting KOP receptors
Associate Advisor
Other advisors: Dr Danial Saifuddin, Professor Peter Cabot
-
Doctor Philosophy
Targeting peripheral kappa and mu bivalent opioid receptors with bivalent opioid peptides for inflammatory pain
Associate Advisor
Other advisors: Dr Ben Ross, Dr Danial Saifuddin, Professor Peter Cabot
-
Doctor Philosophy
Development of novel methods to identify calcium channels and pumps as drug targets in diseases.
Associate Advisor
Other advisors: Professor Gregory Monteith
-
Doctor Philosophy
Engineering a recombinant targeted delivery platform for nucleic acid-based therapeutics
Associate Advisor
Other advisors: Associate Professor Peter Moyle
-
Doctor Philosophy
Mutation Targeting Therapy for Cancer with dCas9
Associate Advisor
Other advisors: Associate Professor Joy Wolfram
-
Doctor Philosophy
Designing novel bivalent ligands that target the Kappa and nociceptin opioid receptors for reduced side effects
Associate Advisor
Other advisors: Dr Rink-Jan Lohman, Dr Danial Saifuddin, Professor Peter Cabot
Completed supervision
-
2025
Doctor Philosophy
Calcium signalling in the context of cell-in-cell structures in a model of entosis in breast cancer cells
Associate Advisor
Other advisors: Professor Gregory Monteith
-
2022
Doctor Philosophy
Shape- and matrix-density mediated changes in calcium signalling in breast cancer cells
Associate Advisor
Other advisors: Professor Gregory Monteith
Media
Enquiries
For media enquiries about Dr Melanie Robitaille's areas of expertise, story ideas and help finding experts, contact our Media team: